+Search query
-Structure paper
| Title | Discovery of RGT-018: A Potent, Selective, and Orally Bioavailable SOS1 Inhibitor for KRAS-Driven Cancers. |
|---|---|
| Journal, issue, pages | Mol. Cancer Ther., Vol. 23, Page 1703-1716, Year 2024 |
| Publish date | Dec 21, 2023 (structure data deposition date) |
Authors | Xiao, F. / Wang, K. / Wang, X. / Li, H. / Hu, Z. / Ren, X. / Huang, W. / Feng, T. / Yao, L. / Lin, J. ...Xiao, F. / Wang, K. / Wang, X. / Li, H. / Hu, Z. / Ren, X. / Huang, W. / Feng, T. / Yao, L. / Lin, J. / Li, C. / Zhang, Z. / Mei, L. / Zhu, X. / Zhong, W. / Xie, Z. |
External links | Mol. Cancer Ther. / PubMed:39087485 |
| Methods | X-ray diffraction |
| Resolution | 2.1 Å |
| Structure data | ![]() PDB-8xjj: |
| Chemicals | ![]() PDB-1lvj: ![]() ChemComp-EDO: ![]() ChemComp-HOH: |
| Source |
|
Keywords | SIGNALING PROTEIN / SOS1 / selective inhibitor / KRAS-driven cancers |
Movie
Controller
Structure viewers
About Yorodumi Papers



Authors
External links



homo sapiens (human)
Keywords